Elliott to support Actelion nominees

Elliott Advisors, the dissident Actelion shareholder which has proposed six independent directors for the Swiss biotech's board, partially welcomed the company's recent nomination of former GlaxoSmithKline boss Jean-Pierre Garnier and ex-Schering-Plough finance chief Robert Bertolini as board members.

Elliott said that while it would support the move, which it characterised as a step in the right direction, it did not go far enough to create real change.